4.6 Review

Clinical implications of the causal relationship between insomnia and depression: how individually tailored treatment of sleeping difficulties could prevent the onset of depression

Journal

EPMA JOURNAL
Volume 2, Issue 3, Pages 287-293

Publisher

SPRINGER INTERNATIONAL PUBLISHING AG
DOI: 10.1007/s13167-011-0079-9

Keywords

Depression; Insomnia; Clinical predictor; Cognitive behaviour therapy for insomnia; First level interventions; Prevention

Funding

  1. European Community [235321]
  2. OPTIMI [248544, FP7-JCT-2009-4]

Ask authors/readers for more resources

Major depression commonly co-occurs with symptoms of insomnia. However, the underlying psychobiological mechanisms which can explain this relationship are still not well understood. Hyperarousal and negative emotionality have been proposed to be possible mediating factors. Several studies have suggested that insomnia could be a predictor of depression. A recent meta-analysis conducted by our group showed that people with insomnia have a two-fold risk to develop depression, compared to people with no sleep difficulties. Thus, early diagnosis and treatment of insomnia could, at least partially, prevent the development of future depression, by identifying people at risk for depression and deliver personalized intervention protocols to improve individual outcome. Modifications of existing treatment modules are needed, as adding sleep protocols to the treatment of depression and affective regulation protocols to the treatment of insomnia, enhance the accessibility for the treatment of insomnia, and develop sleep education protocols in early periods of life.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Sleep quality in persons with mental disorders: Changes during inpatient treatment across 10 diagnostic groups

Adrian Meule, Dieter Riemann, Ulrich Voderholzer

Summary: This study examined the changes in sleep quality during inpatient treatment for mental disorders. The results showed that sleep quality was impaired in all diagnostic groups, with trauma-related disorders having the lowest sleep quality and obsessive-compulsive disorder having the highest sleep quality. While sleep quality improved in all groups, the magnitude of improvement varied, with trauma-related disorders showing the smallest improvement and eating disorders showing the largest improvement.

JOURNAL OF SLEEP RESEARCH (2023)

Article Clinical Neurology

Factors associated with insomnia symptoms: A cross-sectional study during a Covid-19 fully restrictive lockdown

Nausicaa Christodoulou, Lea Bertrand, Laura Palagini, Justine Frija-Masson, Marie-Pia d'Ortho, Michel L. Lejoyeux, Dieter Riennann, Julia Maruani, Pierre A. Geoffroy

Summary: Insomnia symptoms during a fully restrictive lockdown period of Covid-19 are associated with various factors including age, gender, home size, environmental noises, anxiety symptoms, depressive symptoms, regularity of sleep-wake schedules, exposure to screen during the morning, and LED light during the evening. Lifestyle and exposure to natural synchronizers play a crucial role in the development, prevention, and treatment of insomnia, as well as mental health status.

JOURNAL OF SLEEP RESEARCH (2023)

Review Clinical Neurology

How to deal with sleep problems during heatwaves: practical recommendations from the European Insomnia Network

Ellemarije Altena, Chiara Baglioni, Ernesto Sanz-Arigita, Christian Cajochen, Dieter Riemann

Summary: This review examines the impact of heatwaves on night-time temperatures, body temperature, and sleep quality. It discusses the effects of temperature changes on vulnerable populations, such as older adults, children, pregnant women, and individuals with psychiatric conditions. The review suggests various methods, adapted from cognitive behavioural therapy for insomnia, for managing sleep problems during heatwaves. The sparse literature on sleep problems affected by temperature changes highlights the need for further research in this area.

JOURNAL OF SLEEP RESEARCH (2023)

Article Clinical Neurology

How many hours do you sleep? A comparison of subjective and objective sleep duration measures in a sample of insomnia patients and good sleepers

Fee Benz, Dieter Riemann, Katharina Domschke, Kai Spiegelhalder, Anna F. Johann, Nathaniel S. Marshall, Bernd Feige

Summary: The objective of this study was to assess the agreement and linear relationships amongst multiple measures of sleep duration in patients with insomnia disorder and good sleeper controls. The results suggest that subjective and objective measures capture different aspects of sleep, even when addressing the same value. It is important to consider the population being studied and the assessment method when interpreting results.

JOURNAL OF SLEEP RESEARCH (2023)

Editorial Material Clinical Neurology

Focus on sleep-related breathing disorders and COVID-19

Dieter Riemann

JOURNAL OF SLEEP RESEARCH (2023)

Article Clinical Neurology

Associations between insomnia symptoms and functional connectivity in the UK Biobank cohort (n=29,423)

Florian Holub, Roxana Petri, Julian Schiel, Bernd Feige, Martin K. Rutter, Sandra Tamm, Dieter Riemann, Simon D. Kyle, Kai Spiegelhalder

Summary: This study investigates the associations between insomnia symptoms and resting-state functional connectivity at the whole-brain level using a large sample size. The results suggest that frequent insomnia symptoms are associated with altered functional connectivity between brain networks, which may contribute to dysfunctional affective and cognitive processing and impaired sleep.

JOURNAL OF SLEEP RESEARCH (2023)

Article Clinical Neurology

On the relationship between EEG spectral analysis and pre-sleep cognitive arousal in insomnia disorder: towards an integrated model of cognitive and cortical arousal

Raphael J. J. Dressle, Dieter Riemann, Kai Spiegelhalder, Lukas Frase, Michael L. L. Perlis, Bernd Feige

Summary: According to the hyperarousal model, insomnia is characterized by increased arousal in the cortical, cognitive, and physiological domains. However, the interaction between these arousal domains is poorly understood. This observational case-control study investigated cortical arousal during the night, pre-sleep cognitive arousal, and their relationship in patients with insomnia disorder (ID). The study found that patients with ID exhibited increased cortical and cognitive arousal, particularly in the gamma power of EEG spectral analysis. The findings suggest a potential association between pre-sleep worry and rumination and the elicitation of cortical arousal during the night.

JOURNAL OF SLEEP RESEARCH (2023)

Review Clinical Neurology

Hyperarousal in insomnia disorder: Current evidence and potential mechanisms

Raphael J. Dressle, Dieter Riemann

Summary: Insomnia disorder is a common mental disorder, and understanding its causes and mechanisms is crucial. Hyperarousal, characterized by increased arousal in physiological, cortical, and cognitive-emotional domains, plays a significant role in insomnia. There is evidence supporting the involvement of neuroendocrine variables and high-frequency brain activity in cortical arousal. Furthermore, the presence of microarousals during sleep and cognitive-emotional hyperarousal, such as insomnia-related thoughts and worries, contribute to the development of insomnia and comorbid mental disorders.

JOURNAL OF SLEEP RESEARCH (2023)

Article Clinical Neurology

Sleep health dimensions and shift work as longitudinal predictors of cognitive performance in the UK Biobank cohort

Johanna Ell, Julian E. Schiel, Bernd Feige, Dieter Riemann, Casandra C. Nyhuis, Julio Fernandez-Mendoza, Celine Vetter, Martin K. Rutter, Simon D. Kyle, Kai Spiegelhalder

Summary: This study examined the long-term effects of sleep health and shift work on cognitive performance in middle-aged and older adults using data from the UK Biobank. The results indicated that poor sleep health and shift work significantly predicted lower cognitive performance in this population.

SLEEP (2023)

Article Biology

Effects of clozapine-N-oxide and compound 21 on sleep in laboratory mice

Janine Traut, Jose Prius Mengual, Elise J. Meijer, Laura E. McKillop, Hannah Alfonsa, Anna Hoerder-Suabedissen, Seo Ho Song, Kristoffer D. Feher, Dieter Riemann, Zoltan Molnar, Colin J. Akerman, Vladyslav V. Vyazovskiy, Lukas B. Krone

Summary: Designer receptors exclusively activated by designer drugs (DREADDs) are chemogenetic tools for remote control of targeted cell populations using chemical actuators that bind to modified receptors. In this study, we demonstrated that the commonly used DREADD actuator, clozapine-N-oxide (CNO), as well as a novel actuator, compound 21 (C21), can modulate sleep in mice not expressing DREADD receptors. Our findings suggest that back-metabolism to clozapine is not the sole mechanism underlying the sleep effects of chemogenetic actuators.

ELIFE (2023)

Review Clinical Neurology

Insomnia, poor sleep quality and perinatal suicidal risk: A systematic review and meta-analysis

Laura Palagini, Enrico Cipriani, Mario Miniati, Alessandra Bramante, Angelo Gemignani, Pierre A. Geoffroy, Dieter Riemann

Summary: Suicidal risk in mothers is a public health priority, and sleep disturbances are identified as one of the biological factors contributing to increased suicidal risk during the peripartum period. A systematic review revealed that poor sleep quality and insomnia symptoms increase the odds of suicidal risk in pregnant women by more than threefold. Therefore, assessing and addressing sleep disturbances during the peripartum period are crucial in mitigating the adverse effects of peripartum psychopathology and suicidal risk.

JOURNAL OF SLEEP RESEARCH (2023)

Review Clinical Neurology

The importance and limitations of polysomnography in insomnia disorder-a critical appraisal

Lukas Frase, Christoph Nissen, Kai Spiegelhalder, Bernd Feige

Summary: The importance of polysomnography (PSG) in the diagnosis and treatment of insomnia disorder (ID) is a highly debated topic. This review provides a summary of the current scientific knowledge on PSG indications and findings in ID, and the guidelines for conducting PSG in ID. It also discusses important questions regarding ID subtyping to guide personalized pharmacological and psychotherapeutic treatment approaches.

JOURNAL OF SLEEP RESEARCH (2023)

Review Clinical Neurology

Cognitive behavioural therapy for insomnia in inpatient psychiatric care: a systematic review

Carlotta L. Schneider, Elisabeth Hertenstein, Christoph Nissen

Summary: Insomnia is common among psychiatric patients, and cognitive behavioural therapy for insomnia (CBT-I) is the recommended treatment. While CBT-I has been shown to improve insomnia and other health outcomes in outpatient settings, its potential in inpatient psychiatry is unclear. This systematic review identified 10 studies, which reported feasibility and potential efficacy of CBT-I in inpatient settings. However, there is a lack of research on CBT-I in inpatient psychiatry, and adapting CBT-I for severely ill patients in hospital settings could improve mental health care.

JOURNAL OF SLEEP RESEARCH (2023)

Review Clinical Neurology

Cognitive behavioural therapy for insomnia disorder: Extending the stepped care model

Chiara Baglioni, Colin A. Espie, Ellemarije Altena, Dimitri Gavriloff, Susanna Jerneloev, Brigitte Holzinger, Angelika Schlarb, Dieter Riemann

Summary: Although cognitive behavior therapy for insomnia (CBT-I) is the recommended treatment, it is not readily available to those in need. The stepped care model (SCM) offers a solution by providing a pyramid of therapeutics, gradually increasing in intensity, to bridge the treatment gap and distribute resources more effectively. However, high-quality care and training for clinicians, as well as consideration of different interpretations across European countries, are important for successful implementation of the SCM.

JOURNAL OF SLEEP RESEARCH (2023)

Review Clinical Neurology

Comparative short-term safety and efficacy of hypnotics: A quantitative risk-benefit analysis

Janet M. Y. Cheung, Hannah Scott, Alexandria Muench, Ronald R. Grunstein, Andrew D. Krystal, Dieter Riemann, Michael Perlis

Summary: This article aims to provide guidance for the treatment of insomnia by integrating the analysis of medication safety and efficacy. The study found that histamine antagonists have the best safety and risk-benefit profiles, making them the optimal first-line therapy for insomnia.

JOURNAL OF SLEEP RESEARCH (2023)

No Data Available